Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.85p
   
  • Change Today:
      0.000p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 268,316
  • Market Cap: £29.69m
  • Beta: 0.02
Select chart: 1 week | 1 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 39.95 (7.89) (47.42)p n/a n/a n/a n/a 0.0%
31-Dec-26 59.76 0.66 9.35p 0.3 n/a n/a n/a 0.0%
31-Dec-27 90.93 17.42 1.54p 1.8 n/a -84% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2025 40 40 n/a n/a 68 56
31-Dec-2026 60 60 n/a n/a 58 51
31-Dec-2027 91 91 n/a n/a n/a n/a
 
Earnings
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 9.35p 9.38p n/a n/a n/a n/a
31-Dec-2027 1.54p 1.55p n/a n/a n/a n/a
 
Dividend
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 0 1 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 0 1 0 1 1
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 0 2 0 1 1
 
Average Rec 7.50 n/a 7.50 n/a 5.00 5.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 2.85p
Change Today 0.000p
% Change 0.00 %
52 Week High 5.34
52 Week Low 1.60
Volume 268,316
Shares Issued 1,041.69m
Market Cap £29.69m
Beta 0.02

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.68% below the market average11.68% below the market average11.68% below the market average11.68% below the market average11.68% below the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Price Trend
17.36% above the market average17.36% above the market average17.36% above the market average17.36% above the market average17.36% above the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Income Not Available
Growth
63.18% above the market average63.18% above the market average63.18% above the market average63.18% above the market average63.18% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 04-Jul-2025

Time Volume / Share Price
15:50 217 @ 2.75p
12:35 35,294 @ 2.75p
11:07 174,041 @ 2.87p
09:39 58,631 @ 2.75p
09:30 133 @ 3.00p

STX Key Personnel

CEO Anders Lundstrom

Top of Page